Clinuvel Pharmaceuticals | CUV - Ebit



金融业
股票价格
AUD
资产
AUD 269.7M
现金及等价物
AUD 35.2M
销售成本
AUD 2.64M
流动资产
AUD 261.38M
流动负债
AUD 17.85M
债务
AUD 879.78K
股息收益率
0.57
EBIT
AUD 13.51M
EBITDA
AUD 27.55M
员工
16
EPS每股收益
AUD 0.21
股本和储备
AUD 249.02M
销售毛利
AUD 57.82M
债务利息支出
AUD 2.49M
贷款资金
AUD 17.25K
市值
AUD 401.49M
净收入
AUD 10.44M
营业费用
AUD 23.42M
营业利润
AUD 13.51M
普通股股本
AUD 50.2M
PE价格收益
19.34
税前利润
AUD 28.8M
销售收入
AUD 36.93M
销售和管理费用
AUD 3.85M
股票
AUD 9.52M
贸易债权人
AUD 10.68M
应收帐款人
AUD 16.58M


Ebit 更改 日
Avita Medical AUD -10.39M 1.72M 2025-12
Medical Developments International AUD -36K 12.96M 2025-12
Mesoblast USD -54.01M 26.27M 2026-06
Neuren Pharmaceuticals AUD 17.01M 154.09M 2025-12
Pacific Edge NZD -16.94M 2.46M 2026-06
Paradigm Biopharmaceuticals AUD -21.57M 11.26M 2025-12
PYC Therapeutics AUD -22.59M 3.25M 2025-12
Telix Pharmaceuticals AUD 46.36M 38.32M 2026-06